Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
INMD InMode	$14.41 +3.2%	$14.39	$13.14 ▼ $19.85	$882.40M	1.95	1.20 million shs	830,392 shs
MDXG MiMedx Group	$6.76 +1.7%	$6.48	$5.47 ▼ $10.14	$982.22M	1.76	703,050 shs	686,802 shs
SMTI Sanara MedTech	$26.38 +0.4%	$29.42	$25.86 ▼ $39.08	$233.57M	1.3	30,084 shs	29,837 shs
SSII SS Innovations International	$8.45 +0.6%	$6.27	$0.32 ▼ $22.42	$1.63B	N/A	187,980 shs	76,004 shs

7 Stocks to Buy And Hold Forever

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
INMD InMode	+3.22%	+1.12%	+8.51%	-7.51%	-18.82%
MDXG MiMedx Group	+1.65%	+6.79%	+16.35%	-0.29%	-8.65%
SMTI Sanara MedTech	+0.38%	-3.12%	-3.30%	-12.71%	-15.72%
SSII SS Innovations International	+0.60%	+58.54%	+22.11%	+844,999,900.00%	+844,999,900.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
INMD InMode	4.0565 of 5 stars	4.1	4.0	0.0	0.0	2.9	1.7	1.9
MDXG MiMedx Group	3.7061 of 5 stars	3.5	2.0	0.0	0.0	3.1	3.3	1.9
SMTI Sanara MedTech	1.6238 of 5 stars	3.5	1.0	0.0	0.0	0.6	1.7	0.6
SSII SS Innovations International	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
INMD InMode	2.13	Hold	$18.54	28.67% Upside
MDXG MiMedx Group	3.00	Buy	$11.50	70.12% Upside
SMTI Sanara MedTech	3.00	Buy	$49.50	87.64% Upside
SSII SS Innovations International	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest SMTI, MDXG, INMD, and SSII Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/15/2025	MDXG MiMedx Group	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$11.00
7/11/2025	INMD InMode	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold	$15.00
5/15/2025	SMTI Sanara MedTech	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$51.00 ➝ $53.00
4/30/2025	INMD InMode	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$29.00 ➝ $24.00
4/29/2025	INMD InMode	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$19.00 ➝ $16.25
4/29/2025	INMD InMode	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$17.00 ➝ $15.00
4/29/2025	INMD InMode	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral
4/28/2025	INMD InMode	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
4/28/2025	INMD InMode	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Neutral	$22.00 ➝ $16.00
4/28/2025	INMD InMode	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold

(Data available from 7/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
INMD InMode	$394.82M	2.31	$1.88 per share	7.65	$10.12 per share	1.42
MDXG MiMedx Group	$348.88M	2.86	$0.34 per share	20.07	$1.31 per share	5.16
SMTI Sanara MedTech	$86.67M	2.71	N/A	N/A	$4.45 per share	5.93
SSII SS Innovations International	$22.13M	73.92	N/A	N/A	$0.08 per share	105.63

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
INMD InMode	$181.27M	$2.33	6.18	7.92	N/A	44.79%	17.17%	15.20%	7/30/2025 (Estimated)
MDXG MiMedx Group	$42.42M	$0.27	25.04	21.13	N/A	11.40%	22.70%	16.77%	7/30/2025 (Estimated)
SMTI Sanara MedTech	-$9.66M	-$1.34	N/A	N/A	N/A	-12.48%	-29.22%	-13.20%	8/13/2025 (Estimated)
SSII SS Innovations International	-$19.15M	N/A	0.00	∞	N/A	-67.73%	-70.64%	-32.95%	N/A

Latest SMTI, MDXG, INMD, and SSII Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2025	Q2 2025	SMTI Sanara MedTech	-$0.33	N/A	N/A	N/A	$25.15 million	N/A
7/30/2025	Q2 2025	INMD InMode	$0.50	N/A	N/A	N/A	$98.45 million	N/A
7/30/2025	Q2 2025	MDXG MiMedx Group	$0.06	N/A	N/A	N/A	$90.79 million	N/A
5/14/2025	Q1 2025	SMTI Sanara MedTech	-$0.31	-$0.41	-$0.10	-$0.41	$23.48 million	$23.43 million
4/30/2025	Q1 2025	MDXG MiMedx Group	$0.06	$0.06	N/A	$0.05	$86.32 million	$88.21 million
4/28/2025	Q1 2025	INMD InMode	$0.45	$0.31	-$0.14	$0.26	$82.21 million	$77.87 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
INMD InMode	N/A	N/A	N/A	N/A	N/A
MDXG MiMedx Group	N/A	N/A	N/A	N/A	N/A
SMTI Sanara MedTech	N/A	N/A	N/A	N/A	N/A
SSII SS Innovations International	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
INMD InMode	N/A	8.73	7.86
MDXG MiMedx Group	0.09	4.70	4.13
SMTI Sanara MedTech	1.18	2.77	2.54
SSII SS Innovations International	N/A	3.18	2.22

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
INMD InMode	68.04%
MDXG MiMedx Group	79.15%
SMTI Sanara MedTech	8.10%
SSII SS Innovations International	N/A

Insider Ownership

Company	Insider Ownership
INMD InMode	6.92%
MDXG MiMedx Group	1.70%
SMTI Sanara MedTech	42.60%
SSII SS Innovations International	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
INMD InMode	480	63.21 million	58.84 million	Optionable
MDXG MiMedx Group	870	147.70 million	145.19 million	Optionable
SMTI Sanara MedTech	60	8.89 million	5.10 million	Not Optionable
SSII SS Innovations International	4	193.60 million	N/A	N/A

SMTI, MDXG, INMD, and SSII Headlines

Recent News About These Companies

SS Innovations International (NASDAQ:SSII) Shares Gap Down - Here's Why

July 22 at 3:05 PM | marketbeat.com

SS Innovations Announces Completion of World's First Intercontinental Robotic Cardiac Telesurgery

July 22 at 8:45 AM | prismmediawire.comP

SS Innovations Announces Completion of World's First Intercontinental Robotic Cardiac Telesurgery

July 22 at 8:45 AM | globenewswire.com

SS Innovations International (NASDAQ:SSII) Sees Large Volume Increase - Here's Why

July 18, 2025 | marketbeat.com

SS Innovations International (NASDAQ:SSII) Shares Down 7.7% - Should You Sell?

July 18, 2025 | marketbeat.com

SSII - SS Innovations International Inc Ownership | Morningstar

July 17, 2025 | morningstar.comM

SS Innovations International (NASDAQ:SSII) Shares Up 7.1% - Still a Buy?

July 16, 2025 | marketbeat.com

SS Innovations International (NASDAQ:SSII) Shares Gap Up - Here's What Happened

July 15, 2025 | marketbeat.com

SS Innovations Surpasses Milestone of 100 Installations of the SSi Mantra Surgical Robotic System

July 15, 2025 | prismmediawire.comP

SS Innovations International (NASDAQ:SSII) Shares Gap Down - Time to Sell?

July 11, 2025 | marketbeat.com

SS Innovations International (NASDAQ:SSII) Shares Up 13.7% - Here's What Happened

July 10, 2025 | marketbeat.com

SS Innovations Announces Completion of World's First Robotic Telesurgery for Weight Loss with the Company's SSi Mantra 3 Surgical Robotic System

July 10, 2025 | prismmediawire.comP

SS Innovations Announces Completion of World's First Robotic Telesurgery for Weight Loss with the Company's SSi Mantra 3 Surgical Robotic System

July 10, 2025 | globenewswire.com

SS Innovations International (NASDAQ:SSII) Trading Down 8.7% - Should You Sell?

July 8, 2025 | marketbeat.com

SS Innovations International (NASDAQ:SSII) Trading Up 6.4% - Here's Why

July 3, 2025 | marketbeat.com

SS Innovations International (NASDAQ:SSII) Trading Down 5.5% - Here's What Happened

July 2, 2025 | marketbeat.com

SS Innovations International (NASDAQ:SSII) Stock Price Down 4.1% - What's Next?

June 26, 2025 | marketbeat.com

SS Innovations International (NASDAQ:SSII) Shares Up 8.1% - What's Next?

June 24, 2025 | marketbeat.com

SS Innovations: A Speculative Bet On Robotic Surgeries

June 19, 2025 | seekingalpha.com

SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company's SSi Mantra 3 Surgical Robotic System

June 16, 2025 | prismmediawire.comP

SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company's SSi Mantra 3 Surgical Robotic System

June 16, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

SMTI, MDXG, INMD, and SSII Company Descriptions

InMode NASDAQ:INMD

$14.41 +0.45 (+3.22%)

Closing price 07/22/2025 04:00 PM Eastern

Extended Trading

$14.32 -0.09 (-0.59%)

As of 07/22/2025 07:49 PM Eastern

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

MiMedx Group NASDAQ:MDXG

$6.76 +0.11 (+1.65%)

Closing price 07/22/2025 04:00 PM Eastern

Extended Trading

$6.68 -0.09 (-1.26%)

As of 07/22/2025 05:09 PM Eastern

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.

Sanara MedTech NASDAQ:SMTI

$26.38 +0.10 (+0.38%)

Closing price 07/22/2025 04:00 PM Eastern

Extended Trading

$26.40 +0.03 (+0.09%)

As of 07/22/2025 04:28 PM Eastern

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

SS Innovations International NASDAQ:SSII

$8.45 +0.05 (+0.60%)

As of 07/22/2025 04:00 PM Eastern

AVRA Medical Robotics, Inc. develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc. and changed its name to AVRA Medical Robotics, Inc. in November 2015. AVRA Medical Robotics, Inc. was founded in 2015 and is based in Orlando, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time